Latest long-term debt for MDGS: $700K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2023), MDGS shows a long-term debt of $700K. That compares with $3.4M in the prior-year period — down 79.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MDGS's long-term debt is now $700K (was $3.4M) — a 79.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Medigus is outperforming or lagging.
Tracking MDGS's long-term debt over time shows whether Medigus is scaling, shrinking, or reshaping that part of the business. The current reading is $700K That compares with $3.4M in the prior-year period — down 79.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Medigus's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $700K) with ownership activity and broader fundamentals.
Medigus's long-term debt is $700K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.